Supplemental material
Emerging Microbes & Infections
Volume 11, 2022 - Issue 1
Coronaviruses
Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study
Francisco Tsz Tsun Laia Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China;b Laboratory of Data Discovery for Health (D4H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, People’s Republic of China
https://orcid.org/0000-0002-9121-1959View further author information
https://orcid.org/0000-0002-9121-1959View further author information, Gilbert T. Chuac Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China;d Department of Paediatrics and Adolescent Medicine, Hong Kong Children’s Hospital, Hong Kong Special Administrative Region, People’s Republic of Chinahttps://orcid.org/0000-0003-0333-0059View further author information
https://orcid.org/0000-0003-0333-0059View further author information, , , , , , , Xue Lia Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China;b Laboratory of Data Discovery for Health (D4H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, People’s Republic of China;h Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of Chinahttps://orcid.org/0000-0003-4836-7808View further author information
https://orcid.org/0000-0003-4836-7808View further author information, , Carlos King Ho Wonga Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China;b Laboratory of Data Discovery for Health (D4H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, People’s Republic of China;h Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of Chinahttps://orcid.org/0000-0002-6895-6071View further author information
https://orcid.org/0000-0002-6895-6071View further author information, , Ian Chi Kei Wonga Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China;b Laboratory of Data Discovery for Health (D4H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, People’s Republic of China;j Research Department of Practice and Policy, School of Pharmacy, University College London, London, UKCorrespondence[email protected]
https://orcid.org/0000-0001-8242-0014View further author information
https://orcid.org/0000-0001-8242-0014View further author information & Patrick Ipc Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China;d Department of Paediatrics and Adolescent Medicine, Hong Kong Children’s Hospital, Hong Kong Special Administrative Region, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-6797-6898View further author information
https://orcid.org/0000-0002-6797-6898View further author information show all